Bulletin
Investor Alert

Poseida Therapeutics Inc.

NAS: PSTX

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Sep 18, 2020, 4:29 p.m.

/zigman2/quotes/205712311/composite

$

9.67

Change

-0.0017 -0.02%

Volume

Volume 155,678

Quotes are delayed by 20 min

/zigman2/quotes/205712311/composite

Today's close

$ 9.50

$ 9.67

Change

+0.17 +1.79%

Day low

Day high

$9.34

$10.14

Open

52 week low

52 week high

$7.63

$17.62

Open

Insider Actions for Poseida Therapeutics Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
07/14/2020 Eric M. Ostertag
Chief Executive Officer; Director
350,696   Derivative/Non-derivative trans. at $0 per share. 0
07/14/2020 Eric M. Ostertag
Chief Executive Officer; Director
255,845   Derivative/Non-derivative trans. at $0 per share. 0
07/14/2020 Malin Corp. Plc
Director
315,098   Derivative/Non-derivative trans. at $0 per share. 0
07/14/2020 Malin Corp. Plc
Director
690,124   Derivative/Non-derivative trans. at $0 per share. 0
07/14/2020 Malin Corp. Plc
Director
1,168,985   Derivative/Non-derivative trans. at $0 per share. 0
07/14/2020 Malin Corp. Plc
Director
7,013,918   Derivative/Non-derivative trans. at $0 per share. 0
07/14/2020 Malin Corp. Plc
Director
315,098   Derivative/Non-derivative trans. at $0 per share. 0
07/14/2020 Malin Corp. Plc
Director
690,124   Derivative/Non-derivative trans. at $0 per share. 0
07/14/2020 Malin Corp. Plc
Director
1,168,985   Derivative/Non-derivative trans. at $0 per share. 0
07/14/2020 Malin Corp. Plc
Director
7,013,918   Derivative/Non-derivative trans. at $0 per share. 0
07/14/2020 Novartis AG
5,908,089   Derivative/Non-derivative trans. at $0 per share. 0
07/14/2020 Longitude Capital Management Co. LLC
Director
2,464,245   Derivative/Non-derivative trans. at $0 per share. 0
07/14/2020 Malin Corp. Plc
Director
10,000   Acquisition at $16 per share. 160,000
07/14/2020 Longitude Capital Management Co. LLC
Director
250,000   Acquisition at $16 per share. 4,000,000
07/14/2020 Marcea Bland Lloyd
Director
10,000   Acquisition at $16 per share. 160,000

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
15 Purchases
0 Sales
27,625,125
0
Last 6 months
15 Purchases
0 Sales
27,625,125
0
Last 12 months
15 Purchases
0 Sales
27,625,125
0

Officers and Executives

Dr. Eric M. Ostertag
Chief Executive Officer & Director
Mr. Kerry Ingalls
Chief Operating Officer
Mr. Mark J. Gergen
CFO, Director & Chief Business Officer
Dr. Matthew A. Spear
Chief Medical Officer
Dr. Paiman Peter Ghoroghchian
Chief Technology Officer
Mr. Harry J. Leonhardt
Chief Compliance Officer & General Counsel
Ms. Johanna M. Mylet
Vice President-Finance
Mr. Glenn Dourado
Vice President-Business Development
Mr. John P. Schmid
Director
Dr. Catherine J. Mackey
Director
Ms. Marcea Bland Lloyd
Director
Dr. David J. Hirsch
Director
Mr. Sean E. Murphy
Director
Ms. Debra Gessner
Vice President-Regulatory Affairs
Link to MarketWatch's Slice.